1. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease;Abbate;Circ. Res.,2020
2. Betulinic Acid: recent advances in chemical modifications, effective delivery, and molecular mechanisms of a promising antiherbal therapy;Ali-Seyed;Chem. Biol. Drug Des.,2016
3. Benjamin, E.J., Muntner, P., Alonso, A., Bittencourt, M.S., Callaway, C.W., Carson, A.P., Chamberlain, A.M., Chang, A.R., Cheng, S., Das, S.R., Delling, F.N., Djousse, L., Elkind, M.S.V., Ferguson, J.F., Fornage, M.,, Jordan, L.C., Khan, S.S., Kissela, B.M., Knutson, K.L., Kwan, T.W., Lackland, D.T., Lewis, T.T., Lichtman, J.H., Longenecker, C.T., Loop, M.S., Lutsey, P.L., Martin, S.S., Matsushita, K., Moran, A.E., Mussolino, M.E., Oflaherty, M., Pandey, A., Perak, A.M., Rosamond, W.D., Roth, G.A., Sampson, U.K.A., Satou, G.M., Schroeder, E.B., Shah, S.H., Spartano, N.L., Stokes. A., Tirschwell, D.L., Tsao, C.W., Turakhia, M.P., Van Wagner, L.B., Wilkins, J.T., Wong, S.S., Virani, S.S., 2019. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and StrokeStatistics-2019 Update: A Report From the American Heart Association. Circulation 139(10), e56–e528.
4. Role of nuclear factor-κB in atherogenesis;Brand;Exp. Phy.,1997
5. Betulinic acid and its derivatives: a patent review (2008–2013);Csuk;Expert Opin Ther Pat.,2014